OncoMatch/Clinical Trials/NCT05050929
RAPid SimPLE Targeted Radiation Treatment for Brain Metastases
Is NCT05050929 recruiting? Yes, currently enrolling (Jun 2026). This Phase 2 trial studies non-drug interventions for brain metastases, adult.
The aim of the study is to show that rapid, simple targeted radiotherapy to brain metastases with 8 Gy / 1 is non-inferior to 20 Gy / 5 in terms of overall survival for patients with poor prognosis.
Check if I qualifyExtracted eligibility criteria
Disease stage
Metastatic disease required
Demographics
Prior therapy
Cannot have received: whole brain radiation therapy
Exception: if less than 3 months prior to randomization
WBRT less than 3 months prior to randomization
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT05050929 currently recruiting?
Yes, this trial is currently recruiting patients.
Are there prior therapy exclusions?
Yes. Prior whole brain radiation therapy disqualifies patients from enrollment.
Is there an age limit?
Yes. Patients must be 100 years or younger.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify